• Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Soligenix Inc

+ Add to Watchlist

SNGX:US

2.0800 USD 0.0300 1.46%

As of 09:55:55 ET on 08/20/2014.

Snapshot for Soligenix Inc (SNGX)

Open: 2.0800 Day's Range: 2.0800 - 2.0800 Volume: 900
Previous Close: 2.0500 52wk Range: 1.5000 - 2.5000 1-Yr Rtn: +30.82%

Stock Chart for SNGX

No chart data available.
  • SNGX:US 2.0800
  • 1D
  • 1M
  • 1Y
2.0500
Interactive SNGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNGX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5656
Est. EPS (USD) (12/2014) -0.4300
Est. PEG Ratio -
Market Cap (M USD) 41.16
Shares Outstanding (M) 20.08
30 Day Average Volume 27,879
Price/Book (mrq) -
Price/Sale (ttm) 9.8418
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNGX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SNGX

Soligenix, Inc. develops therapeutics and vaccines. The Company researches treatments for gastrointestinal Graft-versus-Host disease and cancer, and develops vaccines for military and civilian applications.

Christopher J SchaberChairman/President/CEORichard StraubeSenior VP/Chief Medical Ofcr
Robert N BreySenior VP/Chief Scientific OfcrJoseph M WaruszVP:Finance/Acting CFO
More Company Profile & Key Executives for SNGX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil